Loading...
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/ https://ncbi.nlm.nih.gov/pubmed/20008620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|